Dalla Pozza R, Hartl D, Bechtold S, Urschel S, Kozlik-Feldmann R, Pankuweit S, Belohradsky B, Netz H
Department of Pediatric Cardiology, University Children's Hospital, Lindwurmstr. 4, 80337, Munich, Germany.
Clin Res Cardiol. 2007 Mar;96(3):168-75. doi: 10.1007/s00392-007-0471-6. Epub 2006 Dec 22.
Recurrent pericarditis is a rare disease in childhood. Nevertheless, it may represent a challenge to the clinician due to its resistance to anti-inflammatory treatment. The initial etiology often remains unclear; specific laboratory parameters predicting the frequency or severity of the recurrences are lacking. We report on four patients with recurrent pericarditis in whom antimyolemmal antibodies (AMLAs) were detected. A prolonged persistence of IgM-type AMLAs was found in three patients: two of them presented with acute inflammation as the initial event and one with 48 recurrences during 5.5 years. The fourth patient showed a fast conversion from IgM to IgG-type AMLAs after a less acute initial presentation and showed 4 mild recurrences during the 48-month follow-up.
We were able to detect AMLAs in four children with recurrent pericarditis. This finding may be attributed to an auto-immunological disease following a first, acute event. We propose the detection of AMLAs in all children with unexplained recurrent pericarditis. Pediatric patients with a persistence of IgM-type AMLAs may face frequent recurrences and should be monitored therefore more closely. In addition, medical treatment may be changed in these patients with a slower tapering of the dosage of steroidal and non-steroidal antiinflammatory drugs.
复发性心包炎在儿童时期是一种罕见疾病。然而,由于其对抗炎治疗具有抗性,可能给临床医生带来挑战。初始病因通常仍不明确;缺乏预测复发频率或严重程度的特定实验室参数。我们报告了4例检测到抗肌膜抗体(AMLA)的复发性心包炎患儿。3例患儿中发现IgM型AMLA持续存在:其中2例最初表现为急性炎症,1例在5.5年中复发48次。第4例患儿在不太急性的初始表现后,AMLA迅速从IgM型转变为IgG型,在48个月的随访期间有4次轻度复发。
我们在4例复发性心包炎患儿中检测到了AMLA。这一发现可能归因于首次急性事件后的自身免疫性疾病。我们建议对所有不明原因的复发性心包炎患儿检测AMLA。持续存在IgM型AMLA的儿科患者可能面临频繁复发,因此应更密切地监测。此外,对于这些患者,可改变药物治疗方案,更缓慢地减少甾体和非甾体抗炎药的剂量。